COSCIENS Biopharma Inc.
COSCIENS Biopharma Inc. (CSCI) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001113423 · CSCI · NASDAQ · as of Jun 9, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001113423 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
COSCIENS Biopharma Inc. (NASDAQ: CSCI) has submitted 910 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 1996. As a Healthcare sector company with CIK 0001113423, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is COSCIENS Biopharma Inc.'s most comprehensive regulatory disclosure. The most recent COSCIENS Biopharma Inc. 10-K was filed on 2026-03-25 for fiscal year ending 2026. Historical CSCI 10-K annual reports are available from 2000 through 2026.
Investors researching COSCIENS Biopharma Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
CSCI SEC Filings · 8 questionsCOSCIENS Biopharma Inc. (CSCI) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 910 filings and access original documents at no cost. COSCIENS Biopharma Inc.'s CIK is 0001113423.